Disitamab vedotin shows phase 3 benefit in HER2-positive breast cancer liver metastases
In a finding that could reshape the treatment landscape for one of the most difficult scenarios in breast cancer care, ...
Tag: Disitamab Vedotin
Disitamab Vedotin Benefits Linked to HER-2 in Urothelial Cancer
In a groundbreaking multi-center, real-world study recently published in BMC Cancer, researchers unveil critical insights into the clinical efficacy of ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!